Teacher Retirement System Of Texas Hutchmed (China) LTD Transaction History

Teacher Retirement System Of Texas

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 03, 2022	BUY	$8.63 - $15.52 $88,940 - $159,949	10,306 New	10,306 $91,000
Q1 2022 May 09, 2022	SELL	$15.52 - $35.65 $1.4 Million - $3.23 Million	-90,466 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$28.89 - $35.33 $2.61 Million - $3.2 Million	90,466 New	90,466 $3.17 Million
Q3 2020 Nov 02, 2020	SELL	$25.8 - $34.61 $197,757 - $265,285	-7,665 Closed	0 $0
Q2 2020 Aug 11, 2020	SELL	$17.65 - $28.05 $183,312 - $291,327	-10,386 Reduced 57.54%	7,665 $211,000
Q1 2020 May 05, 2020	BUY	$15.19 - $29.51 $25,033 - $48,632	1,648 Added 10.05%	18,051 $322,000
Q4 2019 Feb 06, 2020	SELL	$17.17 - $25.95 $247,934 - $374,718	-14,440 Reduced 46.82%	16,403 $411,000
Q3 2019 Oct 28, 2019	BUY	$17.84 - $22.69 $56,606 - $71,995	3,173 Added 11.47%	30,843 $550,000
Q2 2019 Aug 05, 2019	BUY	$22.0 - $31.78 $403,370 - $582,686	18,335 Added 196.41%	27,670 $609,000
Q1 2019 May 06, 2019	BUY	$21.27 - $30.58 $198,555 - $285,464	9,335 New	9,335 $285,000

8.25M

3.8K

2.4K

Ticker HCM
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 172,955,008
Market Cap $3.11B
Description
HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...

Get notified when there are updates to the investment portfolio of Teacher Retirement System Of Texas, based on Form 13F filings with the SEC.

Stay updated on Teacher Retirement System Of Texas with notifications on news.